Anders Göransson
Corporate Officer/Principal bei BACTIGUARD HOLDING AB
Vermögen: 113 658 $ am 30.04.2024
Profil
Anders Göransson is currently working as EVP & Global Head-Licensing at Bactiguard AB and as Head-Licensing & Executive Vice President at Bactiguard Holding AB.
He has a Master's degree in Business Administration from Suffolk University and a graduate degree from the University of Uppsala.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BACTIGUARD HOLDING AB
0,06% | 31.12.2022 | 17 620 ( 0,06% ) | 113 658 $ | 30.04.2024 |
Aktive Positionen von Anders Göransson
| Unternehmen | Position | Beginn |
|---|---|---|
| BACTIGUARD HOLDING AB | Corporate Officer/Principal | 21.05.2023 |
Bactiguard AB
 Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | 23.05.2023 |
Ausbildung von Anders Göransson
| University of Uppsala | Graduate Degree |
| Suffolk University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BACTIGUARD HOLDING AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Bactiguard AB
Bactiguard AB Medical DistributorsDistribution Services Bactiguard AB develops and supplies infection protection solutions to reduce the risk of hospital and healthcare related infections. Its product portfolio, Bactiguard Infection Protection, prevents bacterial adhesion and biofilm formation on medical devices. The firm's products include Infection Prevention Foley Catheter, Central Venous Catheter, and Endotracheal Tube. The company was founded by Nils Peder Christian Kinch on June 13, 2005 and is headquartered in Stockholm, Sweden. | Distribution Services |
